-
1
-
-
0036853627
-
Multiple determinants are involved in HIV coreceptor use as demonstrated by CCR4/CCL22 interaction in peripheral blood mononuclear cells (PBMCs)
-
Agrawal L., Vanhorn-Ali Z., and Alkhatib G. Multiple determinants are involved in HIV coreceptor use as demonstrated by CCR4/CCL22 interaction in peripheral blood mononuclear cells (PBMCs). J. Leukocyte Biol. 72 5 (2002) 1063-1074
-
(2002)
J. Leukocyte Biol.
, vol.72
, Issue.5
, pp. 1063-1074
-
-
Agrawal, L.1
Vanhorn-Ali, Z.2
Alkhatib, G.3
-
2
-
-
1242342131
-
Role for CCR5Δ32 protein in resistance to R5, R5X4, and x4 human immunodeficiency virus type 1 in primary CD4+ cells
-
Agrawal L., Lu X., Qingwen J., VanHorn-Ali Z., Nicolescue V., McDermott D., Murphy P.M., and Alkhatib G. Role for CCR5Δ32 protein in resistance to R5, R5X4, and x4 human immunodeficiency virus type 1 in primary CD4+ cells. J. Virol. 78 5 (2004) 2277-2287
-
(2004)
J. Virol.
, vol.78
, Issue.5
, pp. 2277-2287
-
-
Agrawal, L.1
Lu, X.2
Qingwen, J.3
VanHorn-Ali, Z.4
Nicolescue, V.5
McDermott, D.6
Murphy, P.M.7
Alkhatib, G.8
-
3
-
-
0842264042
-
Specific inhibition of HIV-1 coreceptor activity by synthetic peptides corresponding to the predicted extracellular loops of CCR5
-
Agrawal L., VanHorn-Ali Z., Berger E.A., and Alkhatib G. Specific inhibition of HIV-1 coreceptor activity by synthetic peptides corresponding to the predicted extracellular loops of CCR5. Blood 103 4 (2004) 1211-1217
-
(2004)
Blood
, vol.103
, Issue.4
, pp. 1211-1217
-
-
Agrawal, L.1
VanHorn-Ali, Z.2
Berger, E.A.3
Alkhatib, G.4
-
4
-
-
0029984987
-
Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages
-
Alkhatib G., Broder C.C., and Berger E.A. Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages. J. Virol. 70 (1996) 5487-5494
-
(1996)
J. Virol.
, vol.70
, pp. 5487-5494
-
-
Alkhatib, G.1
Broder, C.C.2
Berger, E.A.3
-
5
-
-
0030642222
-
Design and construction of recombinant vaccinia viruses
-
Broder C.C., and Earl P.L. Design and construction of recombinant vaccinia viruses. Methods Mol. Biol. 62 (1997) 173-197
-
(1997)
Methods Mol. Biol.
, vol.62
, pp. 173-197
-
-
Broder, C.C.1
Earl, P.L.2
-
6
-
-
15244345590
-
Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion
-
Coskun A.K., and Sutton R.E. Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion. J. Virol. 79 7 (2005) 4150-4158
-
(2005)
J. Virol.
, vol.79
, Issue.7
, pp. 4150-4158
-
-
Coskun, A.K.1
Sutton, R.E.2
-
7
-
-
25444461701
-
Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2
-
Feuer G., and Green P.L. Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2. Oncogene 24 39 (2005) 5996-6004
-
(2005)
Oncogene
, vol.24
, Issue.39
, pp. 5996-6004
-
-
Feuer, G.1
Green, P.L.2
-
8
-
-
25444488764
-
History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2
-
Gallo R.C. History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2. Oncogene 24 39 (2005) 5926-5930
-
(2005)
Oncogene
, vol.24
, Issue.39
, pp. 5926-5930
-
-
Gallo, R.C.1
-
9
-
-
0030795690
-
Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46
-
Hadlock K.G., Rowe J., Perkins S., Bradshaw P., Song G.Y., Cheng C., Yang J., Gascon R., Halmos J., Rehman S.M., McGrath M.S., and Foung S.K. Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46. J. Virol. 71 8 (1997) 5828-5840
-
(1997)
J. Virol.
, vol.71
, Issue.8
, pp. 5828-5840
-
-
Hadlock, K.G.1
Rowe, J.2
Perkins, S.3
Bradshaw, P.4
Song, G.Y.5
Cheng, C.6
Yang, J.7
Gascon, R.8
Halmos, J.9
Rehman, S.M.10
McGrath, M.S.11
Foung, S.K.12
-
10
-
-
0028853961
-
Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity
-
He J., Choe S., Walker R., Di Marzio P., Morgan D.O., and Landau N.R. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69 11 (1995) 6705-6711
-
(1995)
J. Virol.
, vol.69
, Issue.11
, pp. 6705-6711
-
-
He, J.1
Choe, S.2
Walker, R.3
Di Marzio, P.4
Morgan, D.O.5
Landau, N.R.6
-
11
-
-
0142244201
-
Implications of glucose transporter protein type 1 (GLUT1)-haplodeficiency in embryonic stem cells for their survival in response to hypoxic stress
-
Heilig C., Brosius F., Siu B., Concepcion L., Mortensen R., Heilig K., Zhu M., Weldon R., Wu G., and Conner D. Implications of glucose transporter protein type 1 (GLUT1)-haplodeficiency in embryonic stem cells for their survival in response to hypoxic stress. Am. J. Pathol. 163 5 (2003) 1873-1885
-
(2003)
Am. J. Pathol.
, vol.163
, Issue.5
, pp. 1873-1885
-
-
Heilig, C.1
Brosius, F.2
Siu, B.3
Concepcion, L.4
Mortensen, R.5
Heilig, K.6
Zhu, M.7
Weldon, R.8
Wu, G.9
Conner, D.10
-
12
-
-
0034863375
-
Human T-cell leukemia virus type 1 receptor expression among syncytium-resistant cell lines revealed by a novel surface glycoprotein-immunoadhesion
-
Jassal S.R., Pohler R.G., and Brighty D.W. Human T-cell leukemia virus type 1 receptor expression among syncytium-resistant cell lines revealed by a novel surface glycoprotein-immunoadhesion. J. Virol. 75 17 (2001) 8317-8328
-
(2001)
J. Virol.
, vol.75
, Issue.17
, pp. 8317-8328
-
-
Jassal, S.R.1
Pohler, R.G.2
Brighty, D.W.3
-
13
-
-
33646508082
-
Infection of CD4(+) T lymphocytes by the human T cell leukemia virus type 1 is mediated by the glucose transporter GLUT-1: evidence using antibodies specific to the receptor's large extracellular domain
-
Jin Q., Agrawal L., Vanhorn-Ali Z., and Alkhatib G. Infection of CD4(+) T lymphocytes by the human T cell leukemia virus type 1 is mediated by the glucose transporter GLUT-1: evidence using antibodies specific to the receptor's large extracellular domain. Virology (2006)
-
(2006)
Virology
-
-
Jin, Q.1
Agrawal, L.2
Vanhorn-Ali, Z.3
Alkhatib, G.4
-
14
-
-
26444555502
-
Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells
-
Jones K.S., Petrow-Sadowski C., Bertolette D.C., Huang Y., and Ruscetti F.W. Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells. J. Virol. 79 20 (2005) 12692-12702
-
(2005)
J. Virol.
, vol.79
, Issue.20
, pp. 12692-12702
-
-
Jones, K.S.1
Petrow-Sadowski, C.2
Bertolette, D.C.3
Huang, Y.4
Ruscetti, F.W.5
-
15
-
-
0345447592
-
The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV
-
Manel N., Kim F.J., Kinet S., Taylor N., Sitbon M., and Battini J.L. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115 4 (2003) 449-459
-
(2003)
Cell
, vol.115
, Issue.4
, pp. 449-459
-
-
Manel, N.1
Kim, F.J.2
Kinet, S.3
Taylor, N.4
Sitbon, M.5
Battini, J.L.6
-
16
-
-
25444495686
-
HTLV-1 tropism and envelope receptor
-
Manel N., Battini J.L., Taylor N., and Sitbon M. HTLV-1 tropism and envelope receptor. Oncogene 24 39 (2005) 6016-6025
-
(2005)
Oncogene
, vol.24
, Issue.39
, pp. 6016-6025
-
-
Manel, N.1
Battini, J.L.2
Taylor, N.3
Sitbon, M.4
-
17
-
-
0028152377
-
Facilitative glucose transporters
-
Mueckler M. Facilitative glucose transporters. Eur. J. Biochem. 219 3 (1994) 713-725
-
(1994)
Eur. J. Biochem.
, vol.219
, Issue.3
, pp. 713-725
-
-
Mueckler, M.1
-
18
-
-
0025277719
-
C-terminal truncated glucose transporter is locked into an inward-facing form without transport activity
-
Oka Y., Asano T., Shibasaki Y., Lin J.L., Tsukuda K., Katagiri H., Akanuma Y., and Takaku F. C-terminal truncated glucose transporter is locked into an inward-facing form without transport activity. Nature 345 6275 (1990) 550-553
-
(1990)
Nature
, vol.345
, Issue.6275
, pp. 550-553
-
-
Oka, Y.1
Asano, T.2
Shibasaki, Y.3
Lin, J.L.4
Tsukuda, K.5
Katagiri, H.6
Akanuma, Y.7
Takaku, F.8
-
19
-
-
0029794456
-
Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system
-
Sutton R.E., and Littman D.R. Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system. J. Virol. 70 10 (1996) 7322-7326
-
(1996)
J. Virol.
, vol.70
, Issue.10
, pp. 7322-7326
-
-
Sutton, R.E.1
Littman, D.R.2
-
20
-
-
11144223212
-
Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects
-
Wang D., Pascual J.M., Yang H., Engelstad K., Jhung S., Sun R.P., and De Vivo D.C. Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann. Neurol. 57 1 (2005) 111-118
-
(2005)
Ann. Neurol.
, vol.57
, Issue.1
, pp. 111-118
-
-
Wang, D.1
Pascual, J.M.2
Yang, H.3
Engelstad, K.4
Jhung, S.5
Sun, R.P.6
De Vivo, D.C.7
-
21
-
-
25444489624
-
Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis
-
Yoshida M. Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene 24 39 (2005) 5931-5937
-
(2005)
Oncogene
, vol.24
, Issue.39
, pp. 5931-5937
-
-
Yoshida, M.1
-
22
-
-
0029131908
-
Glucose transporter function is controlled by transporter oligomeric structure. A single, intramolecular disulfide promotes GLUT1 tetramerization
-
Zottola R.J., Cloherty E.K., Coderre P.E., Hansen A., Hebert D.N., and Carruthers A. Glucose transporter function is controlled by transporter oligomeric structure. A single, intramolecular disulfide promotes GLUT1 tetramerization. Biochemistry 34 30 (1995) 9734-9747
-
(1995)
Biochemistry
, vol.34
, Issue.30
, pp. 9734-9747
-
-
Zottola, R.J.1
Cloherty, E.K.2
Coderre, P.E.3
Hansen, A.4
Hebert, D.N.5
Carruthers, A.6
|